When was Kardium founded?

Kardium was founded in 2007 and raised its 1st funding round 3 years after it was founded.

Where is Kardium located?

Kardium is headquartered in Burnaby, Canada. It is registered at 2900 - 550 Burrard Street, Vancouver.

How many employees does Kardium have?

As of Sep 30, 2026, the latest employee count at Kardium is 695.

Is Kardium a funded company?

Kardium is a funded company, having raised a total of $471M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 22, 2010.

When was the latest funding round of Kardium?

Kardium's latest funding was a $***** Series C round on Jul 08, 2025, with participation from 7 investors.

Where does Kardium rank among its competitors?

Kardium ranks 1st amongst 19 active competitors, of which 12 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Pulsecare Medical Technology, which secured $14M in Nov, 2025.

Who are the top competitors of Kardium?

Kardium's top competitors include Galvanize, Field Medical and Pulse Biosciences. Among them, Pulsecare Medical Technology secured the most recent funding round in November, 2025.

Kardium - 2026 Company Profile, Team, Funding & Competitors

Kardium is a series C company based in Burnaby (Canada), founded in 2007 by Dan Gelbart, Ruslan Nikolaev, Amos Michelson and Sam Lichtenstein. It operates as a Developer of ablation device for atrial fibrillation. Kardium has raised $471M in funding from investors like Fidelity Investments, T. Rowe Price and Janus Henderson Investors. The company has 19 active competitors, including 12 funded and 3 that have exited. Its top competitors include companies like Galvanize, Field Medical and Pulse Biosciences.

Company Details

Kardium is developing the Globe mapping and ablation system. It's an investigational medical device, used in the diagnosis and treatment of atrial fibrillation. It provides mapping, stimulation, and RF ablation of cardiac tissue.

Website: kardium.com
Social
Registered Address: 2900 - 550 Burrard Street, Vancouver

Key Metrics

Founded Year

2007

Location

Burnaby, Canada

Stage

Series C

Total Funding

$471M in 6 rounds

Latest Funding Round

Series C, Jul 08, 2025, $*****

Investors

Fidelity Investments & 11 more

Ranked

1^st among 19 active competitors

Employee Count

695 as on Sep 30, 2026

Similar Companies

Galvanize & 17 more

View Kardium's full profile

Kardium is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Kardium Inc. CIN: 12611210 , Canada, Active	Jan 01, 2021	-	-	-

Kardium has raised a total funding of $471M over 6 rounds. Its first funding round was on Jul 22, 2010. Its latest funding round was a Series C round on Jul 08, 2025 for $*****. 7 investors participated in its latest round. Kardium has 12 institutional investors.

Here is the list of recent funding rounds of Kardium:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 08, 2025	8145169	Series C	1295259	1132993	8696133	4100340
Jun 11, 2024	7302362	Series B	7166235	7907281	9268633	Durable Capital Partners
Dec 30, 2020	5363259	Series B	4705976	9871552	Fidelity Investments	T. Rowe Price

Access funding benchmarks and valuations. Sign up today!

View details of Kardium's funding rounds and investors

The founders of Kardium are Dan Gelbart, Ruslan Nikolaev, Amos Michelson and Sam Lichtenstein.

Here are the details of Kardium's key team members:

Dan Gelbart: Co-Founder of Kardium.
Ruslan Nikolaev: Co-Founder of Kardium.
Amos Michelson: Co-founder & Chairman of Kardium.
Sam Lichtenstein: Co-Founder of Kardium.

View details of Kardium's Founder profiles and Board Members

Kardium's employee count trend

Kardium has 695 employees as of Sep 26. Here is Kardium's employee count trend over the years:

Uncover Kardium's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kardium include Galvanize, Field Medical and Pulse Biosciences. Here is the list of Top 10 competitors of Kardium, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kardium 2007, Burnaby (Canada), Series C	Developer of ablation device for atrial fibrillation	$471M	T. Rowe Price, Fidelity Investments & 10 others	68/100
2nd	Galvanize 2020, San Carlos (United States), Series C	Developer of pulsed electric field systems for various medical indications	$210M	Fidelity Investments, Sofinnova Partners ... & 11 others	58/100
3rd	Field Medical 2022, Encinitas (United States), Series B	Developer of device for the treatment of heart arrhythmia conditions	$89M	BioStar Capital, Cue Growth Partners	56/100
4th	Pulse Biosciences 2014, Burlingame (United States), Acquired	Developer of a platform technology called Nano-Pulse Electro-Signaling	$8M	MDB Capital, Sea Purity Investments & 1 others	50/100
5th	Pulsecare Medical Technology 2021, Shenzhen (China), Series A	Developer of medical device solutions for heart and vascular care	$14M	Oriza Holdings, Loayal Valley Capital & 3 others	50/100
6th	Affera 2014, Boston (United States), Acquired	Developer of devices to treat heart rhythm disorders	-	Innogest Capital, Bain Capital Life Sciences ... & 4 others	47/100
7th	Argá Medtech 2020, Epalinges (Switzerland), Series B	Developer of medical devices for treating cardiac arrhythmias	$58.5M	Advent Life Sciences, Earlybird & 1 others	45/100
8th	Farapulse 2014, Menlo Park (United States), Series C	Advanced cardiac ablation solutions for atrial fibrillation treatment	$36.3M	F-Prime Capital, Boston Scientific & 3 others	42/100
9th	EnChannel Medical 2020, Ladera Ranch (United States), Series B	Developer of medical device for cardiac disorders	$110M	LAV, DragonBall Capital & 2 others	39/100
10th	AtriAN 2017, Galway (Ireland), Seed	Developing the device that targets to atrial fibrillation	$2.56M	Western Development Commission, Mayo Clinic Ventures ... & 4 others	34/100